Alcoholic hepatitis management is one of the most score-dependent clinical pathways in medicine. The decision to treat, the decision to continue treatment, and the prognostic assessment each depend on a specific clinical calculator — and the scores form a sequence, not a menu.
Most online resources cover each score in isolation. Maddrey on one page. Lille on another. MELD on a third. But in practice, they form a single workflow — and understanding the workflow is what the exam tests and what clinical practice demands.
This guide walks through the full sequence from presentation to day 7 decision.
The Clinical Scenario
A 48-year-old man with a history of heavy alcohol use presents with jaundice, tender hepatomegaly, fever, and AST:ALT ratio >2. Blood tests show bilirubin 280 µmol/L, PT 22 seconds (control 12), albumin 26, WCC 14, creatinine 98. This is a typical presentation of severe alcoholic hepatitis.
Step 1 — Maddrey Discriminant Function: Is This Severe?
The Maddrey Discriminant Function (mDF) determines severity — and therefore whether corticosteroid treatment is indicated.
Formula: mDF = 4.6 × (patient PT - control PT) + bilirubin (µmol/L) / 17.1
For our patient: mDF = 4.6 × (22 - 12) + (280 / 17.1) = 46.0 + 16.4 = 62.4
Interpretation: mDF ≥32 = severe alcoholic hepatitis. Without treatment, 30-day mortality is approximately 35-50%. Corticosteroid treatment is indicated.
Calculate Maddrey DF on iatroX.
Management decision: Start prednisolone 40mg once daily for 28 days. Ensure no active infection (blood cultures, CXR, urine culture — infection is a contraindication to steroids). Ensure no active GI bleeding. Start thiamine and nutritional support.
Step 2 — Day 7: The Lille Score — Is the Patient Responding?
After 7 days of prednisolone, the Lille score determines whether the patient is responding to treatment — and therefore whether to continue or stop steroids.
The Lille score uses: age, albumin at day 0, bilirubin at day 0, bilirubin at day 7, creatinine, and PT. The key variable is the change in bilirubin between day 0 and day 7 — a falling bilirubin indicates treatment response.
Interpretation:
- Lille <0.45 — Responder. Continue prednisolone for the full 28-day course. 6-month survival approximately 85%.
- Lille ≥0.45 — Non-responder. Stop prednisolone. Continuing steroids in non-responders adds infection risk without mortality benefit. 6-month survival approximately 25%.
Calculate Lille Score on iatroX.
For our patient: Bilirubin has fallen from 280 to 190 at day 7. Lille score calculates to 0.22 — responder. Continue prednisolone. Complete the 28-day course.
The Lille score is the pivot point. It converts a binary treatment decision (treat/don't treat) into a dynamic treatment decision (continue/stop based on response). This is the aspect that exams test most frequently — the day 7 decision is clinically and educationally the most important step.
Step 3 — MELD: Prognosis and Transplant Consideration
The Model for End-Stage Liver Disease score estimates 90-day mortality in patients with chronic liver disease. It uses bilirubin, creatinine, and INR.
In alcoholic hepatitis, MELD is used for prognostic assessment — particularly in patients who are non-responders to prednisolone (Lille ≥0.45) where the question becomes: is this patient a transplant candidate?
MELD interpretation:
- <10: low mortality risk.
- 10-19: moderate risk (~6% 3-month mortality).
- 20-29: high risk (~20% 3-month mortality).
- 30-39: very high risk (~50% 3-month mortality).
- ≥40: extremely high risk (>70% 3-month mortality).
Calculate MELD on iatroX. MELD-Na incorporates sodium for improved prognostic accuracy.
Transplant for alcoholic hepatitis remains controversial (traditionally requires 6 months abstinence), but early liver transplant for selected non-responders is supported by emerging evidence (Mathurin et al., 2011). MELD ≥21 in a non-responder is a common threshold for transplant discussion.
Step 4 — If Cirrhosis Is Present: Child-Pugh Staging
If the patient has underlying cirrhosis (which many severe alcoholic hepatitis patients do), Child-Pugh classification stages the cirrhosis severity: Class A (5-6 points, well-compensated), Class B (7-9, significant functional compromise), Class C (10-15, decompensated).
This informs long-term management — screening (HCC surveillance, variceal screening), specific medication considerations (avoid hepatotoxic drugs, dose-adjust renally excreted drugs), and transplant workup timing.
The Complete Workflow
- Presentation with suspected alcoholic hepatitis → Maddrey DF.
- mDF ≥32 → severe → start prednisolone 40mg daily (exclude infection and GI bleeding first).
- Day 7 → Lille score.
- Lille <0.45 → responder → continue prednisolone for 28 days.
- Lille ≥0.45 → non-responder → stop prednisolone → calculate MELD for prognosis → consider transplant evaluation if MELD ≥21.
- If cirrhosis present → Child-Pugh for staging → long-term management plan.
All calculators are cross-linked on iatroX — complete the pathway on one platform.